Back

A value-based analysis of the systematic use of dapagliflozin in patients with heart failure

29 August 2025 (15:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Public health and cardiovascular disease Health Economics ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Hector Bueno

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

12 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mrs M. Caido (London, GB)
Abstract Slides Video
Presentation thumbnail
Doctor J. Fei (Beijing, CN)
Abstract
Presentation thumbnail
Doctor C. Huang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Public health and cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Reducing the burden of advanced heart failure: a clinical and economical analysis of an intermittent Levosimendan programme
19 May 2025
thumbnail
Congress Presentation
DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure
30 August 2025
thumbnail
Congress Presentation
Economic Toll of Cardiovascular Disease on Healthcare and Mortality in 50 ESC member countries
31 August 2024
thumbnail
Congress Presentation
Trends of health care costs of heart failure during implementation of SGLT2 inhibitors: Data from Finnish nationwide registers
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources